Opportunities for Pan-Spectrum Drugs against Herpes
Predicting the Unpredictable
GPCR FlAsH-Walk Mapping: A Leap into the Future
A promising projects portfolio
As of today, CQDM has 32 outstanding research projects for a total of nearly $ 40 million invested. These projects are carried out by a network of 400 researchers, including more than 50 graduate students, from 46 research institutions (25 public and 21 private) in Quebec, Canada and internationally. These projects cut across nearly 80 mentors from CQDM’s pharmaceutical companies members.